0001739074-21-000004.txt : 20210225 0001739074-21-000004.hdr.sgml : 20210225 20210225160647 ACCESSION NUMBER: 0001739074-21-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210225 DATE AS OF CHANGE: 20210225 EFFECTIVENESS DATE: 20210225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vera Therapeutics, Inc. CENTRAL INDEX KEY: 0001831828 IRS NUMBER: 812744449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-390559 FILM NUMBER: 21680280 BUSINESS ADDRESS: STREET 1: 170 HARBOR WAY STREET 2: 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-770-0077 MAIL ADDRESS: STREET 1: 170 HARBOR WAY STREET 2: 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0001831828 Vera Therapeutics, Inc. 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA CALIFORNIA 94080 650-770-0077 DELAWARE CDF Therapeutics, Inc. Trucode Gene Repair, Inc. None Corporation true 2016 Marshall Fordyce 170 Harbor Way 3rd Floor South San Francisco CA CALIFORNIA 94080 Executive Officer Director Andrew Cheng 170 Harbor Way 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Scott Morrison 170 Harbor Way 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Beth Seidenberg 170 Harbor Way 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Patrick Enright 170 Harbor Way 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Maha Katabi 170 Harbor Way 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Kurt von Emster 170 Harbor Way 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Biotechnology Decline to Disclose 06b false 2020-10-29 false true false 0 70736334 70736334 0 Includes $5,736,335.77 in cancelled convertible debt and does not include $28,121,124.59 sold to two investors who reside outside the United States. false 23 0 0 0 false Vera Therapeutics, Inc. /s/ Marshall Fordyce Marshall Fordyce Chief Executive Officer 2021-02-17